Landscapes / Companies
OncoTherapy Science, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
1 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | Sep 2027Phase 1 trial completes | |||
| Next date | Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer | ||||
| Open drug page | |||||
About
- No active trial
- OTS167IV, OTSA101-DTPA-111In, OTSA101-DTPA-90Y
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021